BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9165504)

  • 1. High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer.
    Gershanovich M; Hayes DF; Ellmén J; Vuorinen J
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):29-36. PubMed ID: 9165504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of phase II clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women].
    Gershanovich ML; Garin AM; Baltinia D; Kurvet A; Kangas L; Ellmen Iu
    Vopr Onkol; 1997; 43(6):587-95. PubMed ID: 9479357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III trials of toremifene vs tamoxifen.
    Gams R
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):23-8. PubMed ID: 9165503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open phase II study of high-dose toremifene as first-line therapy for advanced breast cancer.
    Hietanen T; Hakala T; Baltina D; Johansson R; Numminen S; Helle L; Valavaara R; Thölix E
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):37-40. PubMed ID: 9165505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving role of toremifene in the adjuvant setting.
    Holli K
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):48-51. PubMed ID: 9165507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer].
    Yamamoto Y; Kawazoe T; Iwase H
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1415-9. PubMed ID: 16227740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer.
    Lewis JD; Chagpar AB; Shaughnessy EA; Nurko J; McMasters K; Edwards MJ
    Cancer; 2010 May; 116(10):2307-15. PubMed ID: 20209619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
    Tominaga T; Kimijima I; Kimura M; Takatsuka Y; Takashima S; Nomura Y; Kasumi F; Yamaguchi A; Masuda N; Noguchi S; Eshima N
    Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients.
    Tomás E; Kauppila A; Blanco G; Apaja-Sarkkinen M; Laatikainen T
    Gynecol Oncol; 1995 Nov; 59(2):261-6. PubMed ID: 7590484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
    Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II and III clinical trials of toremifene for metastatic breast cancer.
    Vogel CL
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):9-13. PubMed ID: 9556785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and II studies of toremifene.
    Hamm JT
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):19-22. PubMed ID: 9165502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment.
    Jönsson PE; Malmberg M; Bergljung L; Ingvar C; Ericsson M; Ryden S; Nilsson I; Terje IJ
    Anticancer Res; 1991; 11(2):873-5. PubMed ID: 1829600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
    Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
    Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
    Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials.
    Zhou WB; Ding Q; Chen L; Liu XA; Wang S
    Breast Cancer Res Treat; 2011 Aug; 128(3):625-31. PubMed ID: 21553116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of estrogen receptors in predicting response to antiestrogens.
    Valavaara R
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):14-8. PubMed ID: 9165501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Eastern European Study Group.
    Gershanovich M; Garin A; Baltina D; Kurvet A; Kangas L; Ellmén J
    Breast Cancer Res Treat; 1997 Sep; 45(3):251-62. PubMed ID: 9386869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
    Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
    J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.